These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36261742)

  • 21. Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis.
    Ai G; Huang R; Xie J; Zhong L; Wu X; Qin Z; Su Z; Chen J; Yang X; Dou Y
    J Ethnopharmacol; 2023 Jan; 301():115775. PubMed ID: 36198377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the NLRP3 inflammasome by HMGB1 through inhibition of the Nrf2/HO-1 pathway promotes bleomycin-induced pulmonary fibrosis after acute lung injury in rats.
    Huang Y; Wang A; Jin S; Liu F; Xu F
    Allergol Immunopathol (Madr); 2023; 51(3):56-67. PubMed ID: 37169561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. γ-Mangostin abrogates AINT-induced cholestatic liver injury: Impact on Nrf2/NF-κB/NLRP3/Caspase-1/IL-1β/GSDMD signalling.
    Khayat MT; Mohammad KA; Mohamed GA; El-Agamy DS; Elsaed WM; Ibrahim SRM
    Life Sci; 2023 Jun; 322():121663. PubMed ID: 37023956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
    Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
    Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Nrf2/HO-1 signaling leads to increased activation of the NLRP3 inflammasome in osteoarthritis.
    Chen Z; Zhong H; Wei J; Lin S; Zong Z; Gong F; Huang X; Sun J; Li P; Lin H; Wei B; Chu J
    Arthritis Res Ther; 2019 Dec; 21(1):300. PubMed ID: 31870428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoxin A4 attenuates MSU-crystal-induced NLRP3 inflammasome activation through suppressing Nrf2 thereby increasing TXNRD2.
    Zhou Y; Chen Y; Zhong X; Xia H; Zhao M; Zhao M; Xu L; Guo X; You CG
    Front Immunol; 2022; 13():1060441. PubMed ID: 36569930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferulic acid protects against methotrexate nephrotoxicity via activation of Nrf2/ARE/HO-1 signaling and PPARγ, and suppression of NF-κB/NLRP3 inflammasome axis.
    Mahmoud AM; Hussein OE; Abd El-Twab SM; Hozayen WG
    Food Funct; 2019 Aug; 10(8):4593-4607. PubMed ID: 31289794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Prospective Ameliorative Role of Zinc Oxide Nanoparticles in STZ-Induced Diabetic Nephropathy in Rats: Mechanistic Targeting of Autophagy and Regulating Nrf2/TXNIP/NLRP3 Inflammasome Signaling.
    Abd El-Khalik SR; Nasif E; Arakeep HM; Rabah H
    Biol Trace Elem Res; 2022 Apr; 200(4):1677-1687. PubMed ID: 34241775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroacupuncture ameliorates cardiopulmonary bypass induced apoptosis in lung via ROS/Nrf2/NLRP3 inflammasome pathway.
    Dhar R; Zhang L; Li Y; Rana MN; Hu Z; Li Z; Cui H; Tang H
    Life Sci; 2019 Dec; 238():116962. PubMed ID: 31628913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders.
    Tastan B; Arioz BI; Genc S
    Front Immunol; 2022; 13():865772. PubMed ID: 35418995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activation.
    Zhao C; Gillette DD; Li X; Zhang Z; Wen H
    J Biol Chem; 2014 Jun; 289(24):17020-9. PubMed ID: 24798340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbe-Derived Antioxidants Reduce Lipopolysaccharide-Induced Inflammatory Responses by Activating the Nrf2 Pathway to Inhibit the ROS/NLRP3/IL-1β Signaling Pathway.
    Shen C; Luo Z; Ma S; Yu C; Gao Q; Zhang M; Zhang H; Zhang J; Xu W; Yao J; Xu J
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The possible protective effect of colchicine against liver damage induced by renal ischemia-reperfusion injury: role of Nrf2 and NLRP3 inflammasome.
    Awad AS; Elariny HA; Sallam AS
    Can J Physiol Pharmacol; 2020 Dec; 98(12):849-854. PubMed ID: 32640174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oridonin attenuates carrageenan-induced pleurisy via activation of the KEAP-1/Nrf2 pathway and inhibition of the TXNIP/NLRP3 and NF-κB pathway in mice.
    Yang H; Huang J; Gao Y; Wen Z; Peng L; Ci X
    Inflammopharmacology; 2020 Apr; 28(2):513-523. PubMed ID: 31552548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells.
    Hu Q; Zhang T; Yi L; Zhou X; Mi M
    Biofactors; 2018 Mar; 44(2):123-136. PubMed ID: 29193391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin attenuates smoking-induced atherosclerosis by activating the Nrf2 pathway via NLRP3 inflammasomes in endothelial cells.
    Zhao Z; Wang X; Zhang R; Ma B; Niu S; Di X; Ni L; Liu C
    Aging (Albany NY); 2021 Apr; 13(8):11363-11380. PubMed ID: 33839695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol protects against CIH-induced myocardial injury by targeting Nrf2 and blocking NLRP3 inflammasome activation.
    Sun ZM; Guan P; Luo LF; Qin LY; Wang N; Zhao YS; Ji ES
    Life Sci; 2020 Mar; 245():117362. PubMed ID: 31996295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
    Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY
    Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hesperetin ameliorates spinal cord injury by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling.
    Liu Z; Tu K; Zou P; Liao C; Ding R; Huang Z; Huang Z; Yao X; Chen J; Zhang Z
    Int Immunopharmacol; 2023 May; 118():110103. PubMed ID: 37001385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1.
    Xiang W; Yang Y; Weng L; Ye Z; Ding P; Li H; Sun J; Zeng C
    Int Immunopharmacol; 2023 May; 118():110085. PubMed ID: 37018978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.